ATE516365T1 - Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer - Google Patents
Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primerInfo
- Publication number
- ATE516365T1 ATE516365T1 AT03752920T AT03752920T ATE516365T1 AT E516365 T1 ATE516365 T1 AT E516365T1 AT 03752920 T AT03752920 T AT 03752920T AT 03752920 T AT03752920 T AT 03752920T AT E516365 T1 ATE516365 T1 AT E516365T1
- Authority
- AT
- Austria
- Prior art keywords
- regions
- seq
- base sequence
- cytokeratins
- primers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002145689 | 2002-05-21 | ||
| JP2002175271 | 2002-06-17 | ||
| JP2002199759 | 2002-07-09 | ||
| PCT/JP2003/006256 WO2003097878A1 (fr) | 2002-05-21 | 2003-05-20 | Amorces d'amplification d'acide nucleique destinees a detecter des cytokeratines et technique d'examen utilisant ces amorces |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516365T1 true ATE516365T1 (de) | 2011-07-15 |
Family
ID=29553987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03752920T ATE516365T1 (de) | 2002-05-21 | 2003-05-20 | Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8076080B2 (de) |
| EP (1) | EP1510587B1 (de) |
| CN (1) | CN1656235B (de) |
| AT (1) | ATE516365T1 (de) |
| AU (1) | AU2003234932A1 (de) |
| WO (1) | WO2003097878A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE516365T1 (de) * | 2002-05-21 | 2011-07-15 | Sysmex Corp | Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer |
| GR1005424B (el) * | 2005-08-17 | 2007-02-01 | Medexis Αεβε | Μεθοδος για τον ποσοτικο προσδιορισμο της εκφρασης της ck19 |
| AU2006281569A1 (en) | 2005-08-17 | 2007-02-22 | Medexis S.A. | Composition and method for determination of CK19 expression |
| JP4968577B2 (ja) * | 2006-04-11 | 2012-07-04 | エフ．ホフマン−ラ ロシュ アーゲー | サイトケラチン１９（ＣＫ１９）ｍＲＮＡの迅速測定法、並びにそのためのプライマー及びプローブ |
| JP2008136386A (ja) * | 2006-11-30 | 2008-06-19 | Sapporo Breweries Ltd | ホップ潜在ウイルスの検出方法、検出用プライマーセット及び検出用キット |
| JP2008136389A (ja) * | 2006-11-30 | 2008-06-19 | Sapporo Breweries Ltd | アップルモザイクウイルスの検出方法、検出用プライマーセット及び検出用キット |
| EP2284281A4 (de) * | 2008-03-28 | 2011-08-10 | Sysmex Corp | Reagens mit primer zum nachweis von mrna für cytokeratin-7 |
| US20140038838A1 (en) | 2012-06-27 | 2014-02-06 | Niven Rajin Narain | Use of markers in the diagnosis and treatment of prostate cancer |
| WO2016094425A1 (en) | 2014-12-08 | 2016-06-16 | Berg Llc | Use of markers including filamin a in the diagnosis and treatment of prostate cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| GB9423912D0 (en) | 1994-11-26 | 1995-01-11 | Imp Cancer Res Tech | Detecting tumours |
| DE69632870T2 (de) * | 1995-03-17 | 2005-07-14 | John Wayne Cancer Institute, Santa Monica | Nachweis von melanomenmetastasen unter verwendung eines mehrfachmarker-tests |
| DE19716346C1 (de) * | 1997-04-18 | 1998-11-19 | Christoph Prof Dr Wagener | Verfahren zum Nachweis von Cytokeratinen |
| EP1873260B1 (de) | 1998-11-09 | 2009-03-18 | Eiken Kagaku Kabushiki Kaisha | Prozess zur Synthetisierung von Nukleinsäure |
| US6468546B1 (en) * | 1998-12-17 | 2002-10-22 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
| US6203992B1 (en) | 1999-10-15 | 2001-03-20 | Abbott Laboratories | Nucleic acid primers and probes for detecting tumor cells |
| IL149933A0 (en) | 1999-12-06 | 2002-11-10 | Gen Hospital Corp | Pancreatic stem cells and their use in transplantation |
| EP1358349A2 (de) * | 2000-06-05 | 2003-11-05 | Avalon Pharmaceuticals | Bestimmung von krebsgenen und therapeutisches screeningverfahren das signaturen von gensätzen verwendet |
| CN1471587A (zh) * | 2000-06-21 | 2004-01-28 | 日立化成工业株式会社 | 肺癌的基因标记 |
| FR2810677B1 (fr) * | 2000-06-27 | 2004-10-01 | Urogene | Procede de diagnostic in vitro du cancer de la prostate et kit de mise en oeuvre |
| US7374913B2 (en) | 2000-09-19 | 2008-05-20 | Eiken Kagaku Kabushiki Kaisha | Method for synthesizing polynucleotides |
| ATE485372T1 (de) * | 2002-01-09 | 2010-11-15 | Sysmex Corp | Nukleinsäurenachweisverfahren und system dafür |
| ATE516365T1 (de) * | 2002-05-21 | 2011-07-15 | Sysmex Corp | Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer |
-
2003
- 2003-05-20 AT AT03752920T patent/ATE516365T1/de not_active IP Right Cessation
- 2003-05-20 AU AU2003234932A patent/AU2003234932A1/en not_active Abandoned
- 2003-05-20 EP EP03752920A patent/EP1510587B1/de not_active Expired - Lifetime
- 2003-05-20 WO PCT/JP2003/006256 patent/WO2003097878A1/ja active Application Filing
- 2003-05-20 CN CN03811447XA patent/CN1656235B/zh not_active Expired - Lifetime
- 2003-05-20 US US10/514,776 patent/US8076080B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003097878A1 (fr) | 2003-11-27 |
| US8076080B2 (en) | 2011-12-13 |
| EP1510587B1 (de) | 2011-07-13 |
| AU2003234932A1 (en) | 2003-12-02 |
| CN1656235A (zh) | 2005-08-17 |
| EP1510587A1 (de) | 2005-03-02 |
| EP1510587A4 (de) | 2007-11-14 |
| US20060094008A1 (en) | 2006-05-04 |
| CN1656235B (zh) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534749T1 (de) | Sonde und primer zum nachweis von tuberkelbazillen sowie verfahren zum nachweis von tuberkelbazillen beim menschen damit | |
| DE60320780D1 (de) | Funktionalisierte nanopartikel und verwendungsverfahren | |
| ATE321883T1 (de) | DE NOVO ODER ßUNIVERSALERß SEQUENZIERUNGS-ARRAY | |
| ATE557083T1 (de) | Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität | |
| EP2366803A3 (de) | Zusammensetzungen und Verfahren zum Nacheis des West Nil Viruses. | |
| ATE364718T1 (de) | Verfahren zur vervielfältigung von nukleinsäure | |
| ATE262595T1 (de) | Methoden und zusammensetzungen zur linearen isothermalen amplifikation von polynukleotidsequenzen | |
| DE60112746D1 (de) | Kälteempfindliche dna-polymerasemutanten | |
| ATE356222T1 (de) | Massives parallelverfahren zur dekodierung von dna und rna | |
| DE60041940D1 (de) | Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren | |
| ES2118593T3 (es) | Analogos de nucleotidos de pteridina como sondas fluorescentes de adn. | |
| DK1569661T3 (da) | Antisense design | |
| DE602005009693D1 (de) | 2"-nitrobenzyl-modifizierte ribonukleotide | |
| WO2004010101A3 (en) | Detection of chemical ligation using fluorescence quenching leaving groups | |
| ATE516365T1 (de) | Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer | |
| DE69842183D1 (de) | Hochempfindliche polymerasen und ihre verwendungen | |
| DE60332781D1 (de) | Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C | |
| ATE554164T1 (de) | Primer für nukleinsäureamplifikation bei der detektion von haushaltsgen-mrna und testverfahren unter verwendung der primer | |
| EP1767653A4 (de) | Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde | |
| ATE312204T1 (de) | Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes | |
| ATE513059T1 (de) | Verfahren zum nachweis oder zur quantitativen bestimmung der mitochondrialen dna-variation 3243 und kit dafür | |
| DE602004028862D1 (de) | Der nukleinsäuren von hiv-1 und hiv-2 | |
| DE60015210D1 (de) | Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung | |
| DE602004015832D1 (de) | Verfahren zum nachweis von genetischem polymorphismus | |
| WO2005017176A3 (en) | Methods for identifying risk of melanoma and treatments thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |